HK2696A - Antitussive liquid compositions containing phenol - Google Patents

Antitussive liquid compositions containing phenol

Info

Publication number
HK2696A
HK2696A HK2696A HK2696A HK2696A HK 2696 A HK2696 A HK 2696A HK 2696 A HK2696 A HK 2696A HK 2696 A HK2696 A HK 2696A HK 2696 A HK2696 A HK 2696A
Authority
HK
Hong Kong
Prior art keywords
phenol
composition
volume
antitussive
liquid compositions
Prior art date
Application number
HK2696A
Other languages
German (de)
English (en)
Inventor
Vincent Sorrentino James
Original Assignee
Richardson-Vicks, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson-Vicks, Inc. filed Critical Richardson-Vicks, Inc.
Publication of HK2696A publication Critical patent/HK2696A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)

Claims (4)

  1. Composition pharmaceutique liquide de matière pour utilisation dans le traitement de la toux et du mal de gorge associé , par absorption directe, comprenant, par dose de 5-30 ml:
    (a) un véhicule pharmaceutique à base aqueuse, acceptable par voie orale;
    (b) de 10 à 30 mg de dextrométhorphane (bromhydrate);
    (c) de 10 à 150 mg de phénol; et
    (d) de 5 à 25 % v/v de co-solvant;
    ladite composition ayant un pH de 5 à 9.
  2. Composition selon la revendication 1, dans laquelle ledit co-solvant en (d) est choisi parmi l'alcool éthylique, le glycérol et le propylèneglycol.
  3. Composition pharmaceutique liquide de matière pour utilisation dans le traitement de la toux et de mal de gorge associé, par absorption directe, comprenant, par dose de 5-30 ml:
    (a) de 20 à 75 % en poids par volume d'eau;
    (b) de 10 à 30 mg de dextrométhorphane (bromhydrate);
    (c) de 50 à 150 mg de phénol; et
    (d) de 10 à 20 % en volume par volume d'alcool éthylique;
    ladite composition ayant un pH de 6 à 7.
  4. Composition selon la revendication 3, dans laquelle (a) consiste en 20-40 % en poids/volume d'eau.
HK2696A 1987-10-27 1996-01-04 Antitussive liquid compositions containing phenol HK2696A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/112,922 US4892877A (en) 1987-10-27 1987-10-27 Antitussive liquid compositions containing phenol

Publications (1)

Publication Number Publication Date
HK2696A true HK2696A (en) 1996-01-12

Family

ID=22346566

Family Applications (1)

Application Number Title Priority Date Filing Date
HK2696A HK2696A (en) 1987-10-27 1996-01-04 Antitussive liquid compositions containing phenol

Country Status (14)

Country Link
US (1) US4892877A (fr)
EP (1) EP0315332B1 (fr)
JP (1) JPH01246221A (fr)
KR (1) KR890006227A (fr)
AT (1) ATE74757T1 (fr)
AU (1) AU624793B2 (fr)
CA (1) CA1333773C (fr)
DE (1) DE3870154D1 (fr)
DK (1) DK598288A (fr)
HK (1) HK2696A (fr)
IE (1) IE60241B1 (fr)
MY (1) MY103434A (fr)
NZ (1) NZ226725A (fr)
PH (1) PH25009A (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5098603A (en) * 1990-01-16 1992-03-24 Eastman Kodak Company Stabilized phenol solution
US5100898A (en) * 1990-01-25 1992-03-31 Richardson-Vicks Inc. Antitussive liquid compositions containing dyclonine
FI931934L (fi) * 1990-10-31 1993-05-31 Procter & Gamble Dextrometorfaninnehaollande hostmedicinkompositioner
US5196436A (en) * 1990-10-31 1993-03-23 The Procter & Gamble Company Dextromethorphan antitussive compositions
US5534552A (en) * 1994-03-02 1996-07-09 Warner-Lambert Company Clear non-alcoholic sinus and allergy medication
AT406120B (de) 1997-08-28 2000-02-25 Immuno Ag Gewebekleber
WO2003011306A1 (fr) * 2001-07-31 2003-02-13 Wyeth Preparation de sucralose permettant de masquer des gouts desagreables
US20060093629A1 (en) * 2004-10-29 2006-05-04 Buehler Gail K Dye-free pharmaceutical suspensions and related methods
US20080305159A1 (en) * 2007-06-06 2008-12-11 Mikart, Inc. Ibuprofen-Hydrocodone-Antihistamine Composition
US20090324734A1 (en) * 2008-06-26 2009-12-31 Daniel Dickey Throat care composition
US8518439B2 (en) * 2008-12-03 2013-08-27 Novartis Ag Liquid therapeutic composition
US20120077778A1 (en) * 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB751767A (en) * 1953-01-21 1956-07-04 Merck & Co Inc Improvements in antitussive compositions
GB1144915A (en) * 1966-11-24 1969-03-12 Armour Pharma Improvements in or relating to pastille formulations
US4029797A (en) * 1973-06-20 1977-06-14 Fisons Corporation Process of making cough syrup with masked noscapine
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
US4212878A (en) * 1978-01-26 1980-07-15 The Upjohn Company Phenylacetamide derivative analgesics
US4374146A (en) * 1980-11-26 1983-02-15 Burroughs Wellcome Co. Topical inflammatory pharmaceutical formulations
US4372942A (en) * 1981-08-13 1983-02-08 Beecham Inc. Candy base and liquid center hard candy made therefrom
US4446140A (en) * 1981-12-10 1984-05-01 Nelson Research & Development Company Method and composition for treating mouth pain
US4636520A (en) * 1984-07-16 1987-01-13 Fujisawa Pharmaceutical Co., Ltd. Antifungal composition employing pyrrolnitrin in combination with an imidazole compound
US4788055A (en) * 1985-12-09 1988-11-29 Ciba-Geigy Corporation Resinate sustained release dextromethorphan composition
US4808410A (en) * 1987-12-16 1989-02-28 Richardson-Vicks Inc. Pharmaceutical compositions containing dyclonine HC1 and phenol
US4945087A (en) * 1988-03-31 1990-07-31 Warner-Lambert Company Taste masking of thymol

Also Published As

Publication number Publication date
DK598288D0 (da) 1988-10-27
MY103434A (en) 1993-06-30
PH25009A (en) 1991-01-28
DK598288A (da) 1989-04-28
ATE74757T1 (de) 1992-05-15
JPH01246221A (ja) 1989-10-02
NZ226725A (en) 1991-11-26
AU2437288A (en) 1989-04-27
EP0315332A1 (fr) 1989-05-10
IE60241B1 (en) 1994-06-15
EP0315332B1 (fr) 1992-04-15
US4892877A (en) 1990-01-09
KR890006227A (ko) 1989-06-12
AU624793B2 (en) 1992-06-25
IE883245L (en) 1989-04-27
DE3870154D1 (de) 1992-05-21
CA1333773C (fr) 1995-01-03

Similar Documents

Publication Publication Date Title
EP0862424B1 (fr) Compositions pharmaceutiques contenant du flurbiprofene
US4778810A (en) Nasal delivery of caffeine
KR20010093255A (ko) 활성성분의 개선된 전달성을 갖는 조성물
US5055461A (en) Anesthetic oral compositions and methods of use
EP0315332B1 (fr) Compositions antitussives liquides contenant du phénol
US5100898A (en) Antitussive liquid compositions containing dyclonine
AU747975B2 (en) Oral liquid antidepressant solution
US20100330176A1 (en) Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
AU2003210345B2 (en) Ambroxol for treating painful conditions in the mouth and pharyngeal cavity
EP0627915B1 (fr) Composition analgesique pulverisable
KR20010093256A (ko) 개선된 안정성을 갖는 조성물
WO2003089007A1 (fr) Compositions pharmaceutiques comprenant un decongestionnant et d'autres ingredients actifs pour traiter la toux et la grippe
AU2003232480B2 (en) Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
KR101122174B1 (ko) 비스테로이드성 소염제를 포함하며 우수한 기호성을 가진약학적 경구 제제
JPH08295637A (ja) 口腔部局所投与剤
US5534552A (en) Clear non-alcoholic sinus and allergy medication
JP2000273051A (ja) 苦みがマスキングされた液状製剤
CA2010022C (fr) Composes anesthesiques oraux
PL168968B1 (en) Method of manufacturing an antitussive drug
US20060198856A1 (en) Ibuprofen suspension stabilized with docusate sodium
US20050136116A1 (en) Stabilized prednisolone sodium phosphate solutions
CA2017923A1 (fr) Composes d'antitussifs pour administration orale
JP3027696B2 (ja) 安定な水性医薬組成物
HK1091404B (en) Pharmaceutical oral dosage form comprising a non-steroidal anti-inflammatory drug, and having good palatability
HK1032012B (en) Oral liquid solution comprising the antidepressant mirtazapine

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)